A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials. Before these laws were enacted, the US Food and Drug Administration (F
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
Despite years of research, the longstanding mystery of where the autophagosome gets its double lipid bilayers is not much clearer.
Unraveling the molecular causes of acute pancreatitis—a potentially deadly disease in which the pancreas essentially digests itself—is yielding clues to how it might be treated.
Our list of the best and brightest products that 2011 had to offer the life scientist
Compounds we perceive as sweet or bitter in the mouth trigger similar receptors and signaling pathways elsewhere in the body, helping to regulate digestion, respiration, and other systems.
Exploiting the unique properties of living systems makes synthetic biologists better engineers.
Designing genomes from scratch will be the next revolution in biology.